Trending Stock News

As Teva Pharm Adr (TEVA) Market Value Declined, Accipiter Capital Management Lowered by $3.24 Million Its Position; Comcast (CMCSA) Shareholder Grand Jean Capital Management Lifted Holding

Teva Pharmaceutical Industries Limited (NYSE:TEVA) Logo

Grand Jean Capital Management Inc increased its stake in Comcast Corp (CMCSA) by 2.11% based on its latest 2017Q4 regulatory filing with the SEC. Grand Jean Capital Management Inc bought 7,980 shares as the company’s stock declined 19.10% with the market. The institutional investor held 385,730 shares of the television services company at the end of 2017Q4, valued at $15.45M, up from 377,750 at the end of the previous reported quarter. Grand Jean Capital Management Inc who had been investing in Comcast Corp for a number of months, seems to be bullish on the $150.20B market cap company. The stock increased 0.28% or $0.09 during the last trading session, reaching $32.64. About 1.53M shares traded. Comcast Corporation (NASDAQ:CMCSA) has declined 11.10% since May 17, 2017 and is downtrending. It has underperformed by 22.65% the S&P500.

Gabe Hoffman decreased its stake in Teva Pharm Adr (TEVA) by 29.81% based on its latest 2017Q4 regulatory filing with the SEC. Accipiter Capital Management Llc sold 180,121 shares as the company’s stock declined 11.04% with the market. The hedge fund run by Gabe Hoffman held 424,064 shares of the major pharmaceuticals company at the end of 2017Q4, valued at $8.04 million, down from 604,185 at the end of the previous reported quarter. Accipiter Capital Management Llc who had been investing in Teva Pharm Adr for a number of months, seems to be less bullish one the $21.08B market cap company. The stock decreased 0.86% or $0.18 during the last trading session, reaching $20.7. About 2.87M shares traded. Teva Pharmaceutical Industries Limited (NYSE:TEVA) has declined 49.50% since May 17, 2017 and is downtrending. It has underperformed by 61.05% the S&P500.

Among 35 analysts covering Teva Pharma (NYSE:TEVA), 9 have Buy rating, 8 Sell and 18 Hold. Therefore 26% are positive. Teva Pharma had 153 analyst reports since July 21, 2015 according to SRatingsIntel. Mizuho maintained the stock with “Hold” rating in Wednesday, October 4 report. Argus Research maintained Teva Pharmaceutical Industries Limited (NYSE:TEVA) on Tuesday, July 28 with “Buy” rating. On Thursday, June 22 the stock rating was maintained by Cantor Fitzgerald with “Hold”. As per Monday, September 18, the company rating was maintained by RBC Capital Markets. The firm has “Sell” rating by BTIG Research given on Monday, February 12. On Monday, August 10 the stock rating was maintained by Goldman Sachs with “Buy”. The rating was downgraded by Argus Research on Tuesday, February 28 to “Hold”. On Monday, May 7 the stock rating was maintained by Morgan Stanley with “Equal-Weight”. The company was downgraded on Monday, November 13 by J.P. Morgan. The firm has “Hold” rating given on Friday, November 4 by HSBC.

Accipiter Capital Management Llc, which manages about $316.20M and $49.19M US Long portfolio, upped its stake in Shire Plc (NASDAQ:SHPG) by 12,738 shares to 50,243 shares, valued at $7.79M in 2017Q4, according to the filing.

Analysts await Teva Pharmaceutical Industries Limited (NYSE:TEVA) to report earnings on August, 2. They expect $0.59 earnings per share, down 40.40% or $0.40 from last year’s $0.99 per share. TEVA’s profit will be $600.75M for 8.77 P/E if the $0.59 EPS becomes a reality. After $0.91 actual earnings per share reported by Teva Pharmaceutical Industries Limited for the previous quarter, Wall Street now forecasts -35.16% negative EPS growth.

More notable recent Teva Pharmaceutical Industries Limited (NYSE:TEVA) news were published by: Globes.Co.Il which released: “Sun: TASE rises despite steep Teva fall” on May 06, 2018, also Seekingalpha.com with their article: “Teva: A Better Entry Point Post-Results” published on May 06, 2018, Fool.com published: “Why Teva Pharmaceutical Industries, Gramercy Property Trust, and Medtronic Jumped Today” on May 07, 2018. More interesting news about Teva Pharmaceutical Industries Limited (NYSE:TEVA) were released by: Investorplace.com and their article: “Teva Pharmaceutical Industries Ltd, Once a Falling Machete, Is Spiking — Chase It” published on May 16, 2018 as well as Seekingalpha.com‘s news article titled: “More states sue over opioid epidemic” with publication date: May 16, 2018.

Since December 14, 2017, it had 0 buys, and 11 sales for $62.58 million activity. ROBERTS BRIAN L sold $25.24 million worth of Comcast Corporation (NASDAQ:CMCSA) on Tuesday, March 13. $4.84 million worth of stock was sold by WATSON DAVID N on Tuesday, March 6. $67,320 worth of Comcast Corporation (NASDAQ:CMCSA) shares were sold by Murdock Daniel C.. Shares for $8.11M were sold by BURKE STEPHEN B on Friday, January 26.

Investors sentiment decreased to 0.93 in Q4 2017. Its down 0.10, from 1.03 in 2017Q3. It is negative, as 75 investors sold CMCSA shares while 544 reduced holdings. 122 funds opened positions while 455 raised stakes. 3.66 billion shares or 0.28% more from 3.65 billion shares in 2017Q3 were reported. Kames Cap Public Ltd stated it has 1.17M shares or 1.19% of all its holdings. Curbstone Management Corp owns 14,452 shares for 0.32% of their portfolio. Glenmede Tru Na reported 0.69% in Comcast Corporation (NASDAQ:CMCSA). Scopus Asset Mgmt Lp holds 0.99% of its portfolio in Comcast Corporation (NASDAQ:CMCSA) for 2.63 million shares. The Minnesota-based Winslow Cap Mngmt Lc has invested 0.53% in Comcast Corporation (NASDAQ:CMCSA). George Kaiser Family Foundation holds 0.48% of its portfolio in Comcast Corporation (NASDAQ:CMCSA) for 35,875 shares. Tudor Investment Corp Et Al reported 5,951 shares. Texas Permanent School Fund reported 0.64% of its portfolio in Comcast Corporation (NASDAQ:CMCSA). Bluefin Trading Limited Liability Corporation accumulated 10,600 shares. Nelson Roberts Inv Advisors Lc invested 0.1% in Comcast Corporation (NASDAQ:CMCSA). Horizon Invest Ltd Limited Liability Company reported 2.81% stake. Cohen Klingenstein Limited reported 1.99% of its portfolio in Comcast Corporation (NASDAQ:CMCSA). Carroll Associate reported 0.04% in Comcast Corporation (NASDAQ:CMCSA). St Germain D J Incorporated owns 13,424 shares. Campbell Newman Asset Mngmt holds 357,707 shares or 2.41% of its portfolio.

Among 32 analysts covering Comcast Corporation (NASDAQ:CMCSA), 23 have Buy rating, 1 Sell and 8 Hold. Therefore 72% are positive. Comcast Corporation had 83 analyst reports since July 27, 2015 according to SRatingsIntel. RBC Capital Markets maintained it with “Outperform” rating and $68 target in Wednesday, October 28 report. Nomura maintained the stock with “Buy” rating in Monday, June 27 report. The stock has “Buy” rating by Jefferies on Thursday, January 25. The stock has “Buy” rating by Oppenheimer on Thursday, July 27. On Friday, January 27 the stock rating was downgraded by Pacific Crest to “Sector Weight”. The rating was maintained by Pivotal Research on Thursday, December 17 with “Buy”. The rating was initiated by Nomura with “Buy” on Tuesday, December 8. UBS maintained Comcast Corporation (NASDAQ:CMCSA) rating on Thursday, March 22. UBS has “Buy” rating and $47 target. On Monday, January 8 the stock rating was maintained by Buckingham Research with “Buy”. The stock has “Buy” rating by Robert W. Baird on Thursday, January 25.

Comcast Corporation (NASDAQ:CMCSA) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *